These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7559747)

  • 1. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.
    Suganuma M; Okabe S; Sueoka E; Nishiwaki R; Komori A; Uda N; Isono K; Fujiki H
    J Cancer Res Clin Oncol; 1995; 121(9-10):621-7. PubMed ID: 7559747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats.
    Suganuma M; Tatematsu M; Yatsunami J; Yoshizawa S; Okabe S; Uemura D; Fujiki H
    Carcinogenesis; 1992 Oct; 13(10):1841-5. PubMed ID: 1330344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.
    Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H
    Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A.
    MacKintosh C; Klumpp S
    FEBS Lett; 1990 Dec; 277(1-2):137-40. PubMed ID: 2176611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
    Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T
    Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein phosphatases (okadaic acid and tautomycin) block sea urchin development.
    Troll W; Sueoka N; Sueoka E; Laskin JD; Heck DE
    Biol Bull; 1995; 189(2):201. PubMed ID: 8541399
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid.
    Fujiki H; Suganuma M
    J Biochem; 1994 Jan; 115(1):1-5. PubMed ID: 8188614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
    Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T
    Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel protein phosphatase inhibitor, tautomycin. Effect on smooth muscle.
    Hori M; Magae J; Han YG; Hartshorne DJ; Karaki H
    FEBS Lett; 1991 Jul; 285(1):145-8. PubMed ID: 1648511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.
    Ubukata M; Koshino H; Yamasaki C; Fujita K; Isono K
    J Antibiot (Tokyo); 1997 Oct; 50(10):801-7. PubMed ID: 9402983
    [No Abstract]   [Full Text] [Related]  

  • 11. Unique features of the okadaic acid activity class of tumor promoters.
    Fujiki H; Suganuma M
    J Cancer Res Clin Oncol; 1999; 125(3-4):150-5. PubMed ID: 10235468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein phosphatases in cyclic AMP-mediated stimulation of hepatic Na+/taurocholate cotransport.
    Mukhopadhyay S; Webster CR; Anwer MS
    J Biol Chem; 1998 Nov; 273(45):30039-45. PubMed ID: 9792726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diarrhetic shellfish toxin, dinophysistoxin-1, is a potent tumor promoter on mouse skin.
    Fujiki H; Suganuma M; Suguri H; Yoshizawa S; Takagi K; Uda N; Wakamatsu K; Yamada K; Murata M; Yasumoto T
    Jpn J Cancer Res; 1988 Oct; 79(10):1089-93. PubMed ID: 3143697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
    Fujiki H; Suganuma M
    Adv Cancer Res; 1993; 61():143-94. PubMed ID: 8394044
    [No Abstract]   [Full Text] [Related]  

  • 15. Okadaic acid stimulates the expression of vascular endothelial growth factor gene.
    Wakiya K; Shibuya M
    Biochem Biophys Res Commun; 1999 Nov; 265(2):584-8. PubMed ID: 10558913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type.
    Yuasa H; Yoshida K; Iwata H; Nakanishi H; Suganuma M; Tatematsu M
    J Cancer Res Clin Oncol; 1994; 120(4):208-12. PubMed ID: 8288675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
    Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
    Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory burst induced by phorbol ester in the presence of tautomycin, a novel inhibitor of protein phosphatases.
    Magae J; Hino A; Isono K; Nagai K
    J Antibiot (Tokyo); 1992 Feb; 45(2):246-51. PubMed ID: 1556017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductions of ornithine decarboxylase and DNA synthesis in rat stomach mucosa by glandular stomach carcinogens.
    Furihata C; Yoshida S; Sato Y; Matsushima T
    Jpn J Cancer Res; 1987 Dec; 78(12):1363-9. PubMed ID: 3123439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatase inhibitors potentiate adrenergic-stimulated cAMP and cGMP production in rat pinealocytes.
    Ho AK; Chik CL
    Am J Physiol; 1995 Mar; 268(3 Pt 1):E458-66. PubMed ID: 7534989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.